INHIBITION OF LENS OPACIFICATION DURING THE EARLY STAGES OF CATARACT FORMATION

被引:0
|
作者
HIRAOKA, T
CLARK, JI
机构
[1] UNIV WASHINGTON, SCH MED, DEPT BIOL STRUCT, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, SCH MED, DEPT OPHTHALMOL, SEATTLE, WA 98195 USA
[3] DOKKYO UNIV, SCH MED, DEPT OPHTHALMOL, MIBU, TOCHIGI 32102, JAPAN
关键词
ANTICATARACT; CATARACT; LENS; OPACITY; PANTETHINE; SELENITE;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. To characterize the time period during cataract formation in which administration of pantethine inhibits lens cell opacification in the selenite model for cataract. Methods. Pantethine was administered to neonatal rat pups at selected time points from -0.5 to 17 hours with respect to injection of selenite at time = 0. The injection dose of pantethine was 820 mg/kg (1.5 mmol/kg) diluted in water at 410 mg/ml concentration. The injection dose of selenite was 3.28 mg/kg (19 mu mol/kg) diluted in saline at 1.8 mg/ml concentration. Opacification was observed using a slit lamp microscope at selected time points over a 14-day period, Cataracts were staged using a classification of opacity from 0 (normal) to 6 (mature). Results. The effect of pantethine was characterized by three different time periods: administration -0.5 to 6 hours with respect to selenite injection provided highly significant protection, P < 0.001; administration 8 hours after selenite provided significant protection, P < 0.005; administration 10 to 17 hours after selenite was not protective. Conclusions. The metabolite pantethine inhibited lens opacification during cataract formation in the selenite model. Even when pantethine was injected several hours after the administration of selenite, opacification was inhibited. Advanced stages of opacification were unresponsive to the administration of pantethine. The inhibitory effect of pantethine was statistically significant when administered during the earliest stage of opacification in the selenite model for cataract.
引用
收藏
页码:2550 / 2555
页数:6
相关论文
共 50 条
  • [21] INHIBITION OF POSTERIOR CAPSULAR OPACIFICATION IN A CATARACT SURGERY MOUSE MODEL
    Hupy, M. L.
    Petrash, M.
    Pedler, M. G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 128 - 128
  • [22] LENS THICKNESS IN EARLY CATARACT
    PERKINS, ES
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1988, 72 (05) : 348 - 353
  • [23] Aminoguanidine-treatment results in the inhibition of lens opacification and calpain-mediated proteolysis in Shumiya cataract rats (SCR)
    Inomata, M
    Hayashi, M
    Shumiya, S
    Kawashima, S
    Ito, Y
    JOURNAL OF BIOCHEMISTRY, 2000, 128 (05): : 771 - 776
  • [24] The effect of sorbitol dehydrogenase inhibition on sugar cataract formation in cultured rat lens
    Oates, PJ
    Coutcher, JB
    Mylari, BL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 895 - 895
  • [25] PREVENTION OF LENS OPACIFICATION DURING DIABETIC VITRECTOMY
    HAIMANN, MH
    ABRAMS, GW
    BLANKENSHIP, GW
    OPHTHALMOLOGY, 1984, 91 (02) : 116 - 121
  • [26] A method for the selection of cataract disintegrating compounds and their use for reversal of crystalline lens opacification
    Zayit-Soudry, Shiri
    Mimouni, Michael
    Chemerovski-Glikman, Marina
    Dagan, Yarden
    Haj, Esraa
    Adler-Abramovich, Lihi
    Segal, Daniel
    Gazit, Ehud
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [27] LENS HEXITOLS AND CATARACT FORMATION DURING LACTATION IN A WOMAN HETEROZYGOTE FOR GALACTOSEMIA
    BRIVET, M
    MIGAYRON, F
    ROGER, J
    CHERON, G
    LEMONNIER, A
    JOURNAL OF INHERITED METABOLIC DISEASE, 1989, 12 : 343 - 345
  • [28] CHANGES IN LENS DURING THE FORMATION OF X-RAY CATARACT IN RABBITS
    PIRIE, A
    VANHEYNINGEN, R
    BOAG, JW
    BIOCHEMICAL JOURNAL, 1953, 54 (05) : 682 - 688
  • [29] STUDIES ON THE OXIDATION OF CYSTEINE TO CYSTINE IN LENS PROTEINS DURING CATARACT FORMATION
    DISCHE, Z
    ZIL, H
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1951, 34 (05) : 104 - 113
  • [30] CHANGES IN LENS FATTY ACID COMPOSITION DURING GALACTOSE CATARACT FORMATION
    HATCHER, H
    ANDREWS, JS
    INVESTIGATIVE OPHTHALMOLOGY, 1970, 9 (10): : 801 - &